MERRIMACK PHARMACEUTICALS IN - COM (MACK)

CUSIP: 590328100

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
96,010,387
Share change
+9,712,229
Total reported value
$609,409,145
Put/Call ratio
144%
Price per share
$6.35
Number of holders
122
Value change
+$63,458,813
Number of buys
59
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 590328100?
CUSIP 590328100 identifies MACK - MERRIMACK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q3 2016

As of 30 Sep 2016, MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 96,010,387 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Fund Advisors, Consonance Capital Management LP, TIAA CREF INVESTMENT MANAGEMENT LLC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., TEACHERS ADVISORS, LLC, and PUTNAM INVESTMENTS LLC. This page lists 122 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.